Tower Research Capital LLC (Trc) Immix Biopharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 471 shares of IMMX stock, worth $993. This represents 0.0% of its overall portfolio holdings.
Number of Shares
471
Previous 181
160.22%
Holding current value
$993
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IMMX
# of Institutions
25Shares Held
3.35MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY850KShares$1.79 Million0.49% of portfolio
-
Cable Car Capital LLC San Francisco, CA779KShares$1.64 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA699KShares$1.47 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$854,55011.13% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$339,1650.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $29.4M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...